Will health insurance cover Flortaucipir F 18?

Flortaucipir F 18 is a radioactive tracer used in positron emission tomography (PET) scans to detect the presence of tau protein in the brain.

Tau protein is relevant to health insurance coverage as it is used in the diagnosis and monitoring of certain neurological conditions, such as Alzheimer’s disease. Health insurance coverage may be sought for PET scans using Flortaucipir F 18 to aid in the diagnosis and management of such conditions.

Health insurance coverage for Flortaucipir F 18 PET scans can vary depending on the specific insurance plan and the medical necessity criteria set by the insurance provider. It is advisable to check with the insurance company directly to determine coverage eligibility.

Factors that can influence health insurance coverage for Flortaucipir F 18 PET scans include the specific insurance plan, the medical necessity criteria defined by the insurance provider, and the diagnosed condition or symptoms requiring the scan. Pre-authorization may be required in some cases.

Alternative methods of coverage for Flortaucipir F 18 PET scans may include participation in clinical trials or research studies, where the cost of the scan may be covered by the study sponsor. Additionally, some hospitals or imaging centers may offer financial assistance programs for patients who do not have insurance coverage.

Yes, Flortaucipir F 18, also known as Tauvid, has received approval from the U.S. Food and Drug Administration (FDA) for use in PET imaging of the brain to assess the presence and distribution of tau pathology associated with Alzheimer’s disease.